The global medical tricorder market was valued at USD 2,951.5 million in 2019 and is expected to grow at a CAGR of 6.66% during 2020-2027. The growth of this market is attributed towards the notable technological advancements achieved in development of medical tricorders, growing preference for outpatient services, increasing prevalence of diabetes and cardiovascular disorders along with growing awareness among the patients. For instance, according to Vox Media, LLC March 2019 publication, in their quest to develop medical tricorder, Google Inc.’s researchers have strategically created an algorithm for deep learning that is capable of detecting diabetic retinopathy disorder with high accuracy or nearly 98% specificity as well as sensitivity score in range of about 87% to 90%.
Additionally, the ongoing COVID-19 pandemic worldwide also drives the demand for advanced medical technology such as the medical tricorder which can be deployed by any individual to check their body temperature. Moreover, the medical tricorder can even determine other key health parameters of any person such as blood pressure, breathing pace, appetite, etc. This is crucial while checking people regarding whether they are infected by the highly contagious COVID-19 disease and proactively sending them in quarantine to prevent the spread of Coronavirus disease.
Know more about this report:request for sample pages
Growth Drivers
加速Covid-19案件的数量全球驱动医疗三凌机设备的需求,可以由他们家中的任何个人用于自我诊断目的。医疗三凌机产生的医学考试报告可以通过智能手机对医疗保健设施的医疗保健从业者进行数字传输。乐动娱乐官网该设施避免了患者在医院或其他医疗机构的身体存在,从而最大限度地减少了高度传染性Covid-19大流行的蔓延的机会。乐动娱乐官网此外,在家中医学诊断和治疗的偏好也提高了家庭中的医疗三凌话的部署,以便自我诊断,也推动了全球市场增长。
In addition, the governments worldwide have also instructed people with very mild symptoms of COVID-19 to remain in home isolation. This has been done to reduce the crowding of patients at the healthcare facilities. For instance, according to the Economic Times, April 2020, publication, Health Ministry of India has issued strict guidelines for people who have extremely mild symptoms or are pre-symptomatic to COVID-19 to remain under home isolation and need not visit any nearby healthcare facility. Such an instruction also boost the demand for medical tricorder device which can be portably used by people at their home for self-diagnosis purpose.
Furthermore, substantial funding received by the global market players for development of advanced medical devices that are closer to medical tricorder is also expected to propel market growth. For instance, according to the nextBIG Future April 2017 publication, Final Frontier Medical Devices has received approximately USD2.5 million funding to boost their research and development activities in developing the DxtER, an advanced artificial intelligence (AI)-driven engine. This AI-based engine uniquely integrates primary clinical outcomes derived from the patients with medicines that are administered to patients under emergency conditions. In addition, DxtER also comprise of several sensors that are non-invasive in nature and being used to capture key signs of body such as biological functions and body chemistry. This major clinical information is then processed in the diagnostic engine of DxtER device for making precise and quick assessments.
The market is primarily segmented on the basis of type, application, end-Use, and geographic region.
按类型 |
通过申请 |
通过最终使用 |
按地区 |
|
|
|
|
Know more about this report:request for sample pages
Based upon type, the global market is categorized into USB camera, fiber optic camera, wireless, corded and others. Of all, the wireless segment held the largest share in the global market in 2019, owing to the extensive deployment of wireless medical tricorders by the end-users worldwide.
根据自主新闻2017年6月出版,两支研究人员团队赢得了可追溯到多种疾病的无线和手持设备的着名高通赛X奖。该无线手持设备能够检查患者的重要健康参数,而无需执行侵入性的任何诊断测试,该设备类似于Startrek电视系列中所示的医疗三凌机设备。
在申请的基础上,全球市场分为诊断,监测和其他市场。在所有情况下,诊断在2019年持有全球市场的最大份额,主要是由于医疗三凌话的实质性诊断应用,可用于诊断一系列疾病,如Covid-19,癌症,哮喘,结核,艾滋病毒艾滋病,糖尿病,心血管疾病(CVDS),中风,关节炎,痴呆,除了别人。
On the basis of end-use, the global medical tricorder market is segmented into hospitals, clinics and others. Of all, hospitals held the largest share in the global market in 2019 mainly driven by growing preference of healthcare professionals such as doctors, surgeons, nurses and clinicians to use portable medical tricorder for diagnosis of patients. Owing to the huge crowd of patients at hospitals amid the ongoing COVID-19 pandemic, medical tricorder is expected to be very successful in maintaining the much required safe-distancing between the healthcare providers and patients.
此外,缺乏高新的医疗保健设施,如医院的床,适应大量患者的能力,同时乐动娱乐官网诊断患者若干疾病也推动了医院对医院医疗特写的需求。
地理位置上,北美预计在欧洲和亚太地区的市场份额之后,北美将在全球医疗三凌机市场中占据主导地位。北美占据了患者池中崛起的主导市场份额,加上了对该地区Covid-19大流行病的增强技术的日益增长的技术需求。例如,根据世界家的据此,在2020年8月的更新中,该地区注册了近699万个Covid-19案件,即美国和加拿大分别记录了约592万和0.13亿元的Covid-19案件。因此,对该地区的医疗特写方面存在显着需求,以便为患者提供基于家庭的自我诊断工具,同时最小化医疗保健设施的患者拥挤。乐动娱乐官网
预计欧洲北美信用卡诈骗罪ring the market share and capture the second largest share of the market. The major market growth driving factors for Europe include, notable healthcare infrastructure investments, rising demand of people for home-based diagnosis and rising chronic disease across the European region. For instance, according to the King's Fund October 2019 release, the government of UK targets on investing approximately USD 3.55 billion (£2.7 billion) for development of nearly 6 National Health Service (NHS) hospitals over the period 2020 to 2025. This key investment is expected to drive the deployment of medical tricorder in healthcare facilities to proactively implement social-distancing in hospitals thereby, driving market growth in Europe.
Asia-Pacific is expected to grow the fastest with highest CAGR over the forecast period primarily attributed to growing demand for medical tricorder from developing countries such as China, India and South Korea. The rising incidence of chronic ailments such as cardiovascular diseases, increasing geriatric population, and accelerating improvement in the healthcare infrastructure facilities in the countries across the region. There’s significant growth potential of emerging economies such as China and India driven by increasing government investments to improve healthcare infrastructure and growing number of chronic disease patients across the countries in the region.
在全球市场中运营的主要参与者专注于收购其他市场参与者,以加强其市场地位。战略收购促进了全球市场参与者的研发能力,并提供竞争优势。
在全球市场上运营的一些主要参与者包括Quantumdx Group Ltd.,Ibis Biosciences,Ionis Pharmaceutical,Cloud DX,Qualcomm Technologies,Inc。,Basil Lead Technologies,LLC,Welfo Fiber Optims,Fujikura Ltd.,Basler Ag,Hamamatsu PhotonicsK.K., and Scanadu.